$DARE has been mentioned by three distinct FinTwit voices five times over the past 12 months, with the first mention appearing on April 16, 2026. The most active voices discussing the stock are @blackpanthercap and @investmentguru_, each with two mentions, followed by @ckcapitalxx with one mention. The most recent discussion occurred on June 20, 2026, when @ckcapitalxx characterized $DARE as a clinical stage pharmaceutical company subject to significant volatility from clinical trial outcomes and data releases.